
A retrospective study comparing simplified and complex amikacin dosing regimens in neonates found both achieved 100% target attainment for key pharmacokinetic/pharmacodynamic (PK/PD) parameters, including Cmax ≥ 15 mg/L and AUC/MIC for bacteriostasis. Both regimens were effective for Enterobacterales MIC ≤ 2 mg/L. Clinicians can select either approach based on local resources and electronic prescription tools to optimize neonatal sepsis treatment.
Like
Save
Share